|
Ding WY, Rivera-Caravaca JM, Marin F, Roldan V, Lip GYH. Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial. J Thromb Thrombolysis. 2022 Jul;54(1):1-6. doi: 10.1007/s11239-022-02638-0. Epub 2022 Apr 15. PubMed PMID: 35426602; PubMed Central PMCID: PMC9259516.
AÑO: 2022; IF: 4.0
|
35426602
|
de Los Reyes-Garcia AM, Rivera-Caravaca JM, Zapata-Martinez L, Aguila S, Veliz-Martinez A, Garcia-Barbera N, Gil-Perez P, Guijarro-Carrillo PJ, Orenes-Pinero E, Lopez-Garcia C, Lozano ML, Marin F, Martinez C, Gonzalez-Conejero R. MiR-146a Contributes to Thromboinflammation and Recurrence in Young Patients with Acute Myocardial Infarction. J Pers Med. 2022 Jul 20;12(7):1185. doi: 10.3390/jpm12071185. PubMed PMID: 35887682; PubMed Central PMCID: PMC9318357.
AÑO: 2022; IF: 3.508
|
|
Lopez-Galvez R, Rivera-Caravaca JM, Anguita Sanchez M, Sanmartin Fernandez M, Rafols C, Perez-Cabeza AI, Baron Esquivias G, Lekuona Goya I, Vazquez Rodriguez JM, Cosin Sales J, Arribas Ynsaurriaga F, Barrios V, Freixa-Pamias R, Marin F. Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study. Eur J Clin Invest. 2022 Sep;52(9):e13788. doi: 10.1111/eci.13788. Epub 2022 Apr 14. PubMed PMID: 35395094.
AÑO: 2022; IF: 5.5
|
|
Rivera-Caravaca JM, Roldan V, Martinez-Montesinos L, Vicente V, Lip GYH, Marin F. The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort. J Gen Intern Med. 2023 Feb;38(2):315-323. doi: 10.1007/s11606-022-07567-5. Epub 2022 Apr 11. PubMed PMID: 35411538; PubMed Central PMCID: PMC9905403.
AÑO: 2023; IF: 4.3
|
|
Lopez-Galvez R, Marin F, Rivera-Caravaca JM. Predicting heart failure in atrial fibrillation patients: What about using biomarkers? Am Heart J. 2022 Sep;251:32-34. doi: 10.1016/j.ahj.2022.05.007. Epub 2022 May 7. No abstract available. PubMed PMID: 35537504.
AÑO: 2022; IF: 4.8
|